Loading cancer entity…
Loading cancer entity…
Clinical trials
806 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06402695 | Observational Study on GEP-and Pulm-NET Treated at FPG(ETNA-FPG) | unknown | — | 650 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | May 7, 2024 | clinicaltrials |
| NCT00970970 | Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease(VHLimage) | completed | — | 22 | University Medical Center GroningenOTHER |
| 1 |
| May 6, 2024 |
| clinicaltrials |
| NCT01398306 | Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.(BANN) | completed | — | 40 | University Medical Center GroningenOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT01849523 | Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor: a Randomized Pilot Study(WIN) | completed | N/A | 20 | University Medical Center GroningenOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT02147106 | Use of Video Consultation in Follow-up Care for Patients With a Neuroendocrine Tumor: a Feasibility Study(VIDEO-NET) | completed | — | 26 | University Medical Center GroningenOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT02472678 | Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor(WIN) | completed | N/A | 91 | University Medical Center GroningenOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT02481804 | Optimal Feeding for NET Patients(DIVIT-pilot) | completed | N/A | 15 | University Medical Center GroningenOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT02507908 | 5-HIAA in Urine Versus 5-HIAA in Plasma Patients With a Serotonin Producing Neuroendocrine Tumor'(5-HIAA) | completed | — | 59 | University Medical Center GroningenOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT02646644 | Heterogeneity of Metastatic Neuroendocrine Tumors as Determined With 18F-dihydroxyphenylalanine-PET /CT, a Retrospective Analysis(HET-NET) | completed | — | 38 | University Medical Center GroningenOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT02815969 | The Indol Profile; Exploring the Metabolic Profile of Neuroendocrine Tumors | completed | — | 210 | University Medical Center GroningenOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT03143946 | DIVIT Study Diet and Vitamin Supplementation in Patients With a Neuroendocrine Tumor | completed | N/A | 53 | University Medical Center GroningenOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT03870399 | Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression(HORMONET) | completed | Phase 2 | 23 | AC Camargo Cancer CenterOTHER | 2 | May 6, 2024 | clinicaltrials |
| NCT04614766 | A Clinical Trial Evaluating the Safety of Combining Lutathera(R) and Azedra(R) to Treat Mid-gut Neuroendocrine Tumors(SPORE-3) | withdrawn | Phase 1 / Phase 2 | 0 | David BushnellOTHER | 1 | Apr 29, 2024 | clinicaltrials |
| NCT05359146 | Combined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist Labelled With Terbium-161 (161Tb-DOTA-LM3)(Beta plus) | unknown | Early Phase 1 | 16 | University Hospital, Basel, SwitzerlandOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT04814732 | Expanded Access Program of Surufatinib | no longer available | — | — | HutchmedINDUSTRY | 1 | Apr 12, 2024 | clinicaltrials |
| NCT05476978 | Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions | completed | — | 130 | Huazhong University of Science and TechnologyOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT06156020 | Outcome Analysis of Endoscopic Resection of Pituitary Adenomas | unknown | N/A | 500 | National Cheng-Kung University HospitalOTHER | 1 | Mar 21, 2024 | clinicaltrials |
| NCT06321692 | Early Identification of Cardiac Involvement in Patients With Carcinoid: Clinical and Prognostic Implications | unknown | N/A | 100 | European Institute of OncologyOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT05475210 | 177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors | unknown | Phase 1 | 9 | Molecular Targeting Technologies, Inc.INDUSTRY | 1 | Mar 13, 2024 | clinicaltrials |
| NCT05334290 | Financial Toxicity and Patient-Reported Outcomes in GEP-NEN During Treatment(FiReNEN) | unknown | — | 400 | Massimo FalconiOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT06300216 | A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors | not yet recruiting | — | 500 | Qilu Hospital of Shandong UniversityOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT06159920 | Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Neuroendocrin Tumors. | unknown | — | 800 | IRCCS San RaffaeleOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT01466036 | Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors | completed | Phase 2 | 61 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 5, 2024 | clinicaltrials |
| NCT05069220 | 18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor | recruiting | Early Phase 1 | 150 | Peking Union Medical College HospitalOTHER | 1 | Mar 1, 2024 | clinicaltrials |
| NCT03022188 | Nonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic Incidentaloma | active not recruiting | — | 100 | Société Française d'Endoscopie DigestiveOTHER | 2 | Feb 21, 2024 | clinicaltrials |
| NCT03834701 | Endoscopic Ultrasound-guided RadioFrequency Ablation for the Treatment Pancreatic NeuroEndocrine Neoplasms(RAPNEN) | completed | N/A | 60 | Catholic University of the Sacred HeartOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT01525082 | Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors | completed | Phase 2 | 20 | Shaheen ShaguftaOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT06234553 | Application of Radiomics in the Diagnosis and Treatment Prediction of Pituitary Adenoma(RIPA) | unknown | — | 200 | Beijing Tiantan HospitalOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT01763554 | Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014 | unknown | — | 115 | AHS Cancer Control AlbertaOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT03084770 | Asymptomatic Small Pancreatic Endocrine Neoplasms.(ASPEN) | unknown | — | 1,000 | IRCCS San RaffaeleOTHER | 1 | Jan 18, 2024 | clinicaltrials |
| NCT06211803 | Clinical Application of the Prototype J-PET Device(JPETClinic) | completed | — | 10 | Jagiellonian UniversityOTHER | 1 | Jan 18, 2024 | clinicaltrials |
| NCT03873870 | 68Ga-DOTATATE PET for Management of Neuroendocrine Tumors | completed | N/A | 1,916 | University Health Network, TorontoOTHER | 1 | Jan 17, 2024 | clinicaltrials |
| NCT03420521 | Nivolumab With Ipilimumab in Subjects With Neuroendocrine Tumors | terminated | Phase 2 | 9 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT02399215 | Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors | completed | Phase 2 | 32 | Roswell Park Cancer InstituteOTHER | 1 | Dec 26, 2023 | clinicaltrials |
| NCT04889742 | Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors(HETERERO) | not yet recruiting | Phase 2 | 110 | Charite University, Berlin, GermanyOTHER | 1 | Dec 26, 2023 | clinicaltrials |
| NCT06155318 | 68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours | recruiting | — | 300 | IRCCS San RaffaeleOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT04452396 | CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia | terminated | N/A | 7 | Barts & The London NHS TrustOTHER | 1 | Dec 12, 2023 | clinicaltrials |
| NCT06167421 | Comparison of Kimura Versus Warshaw Technique for Laparoscopic Spleen-Preserving Distal Pancreatectomy | not yet recruiting | N/A | 240 | Fudan UniversityOTHER | 0 | Dec 12, 2023 | clinicaltrials |
| NCT02859064 | Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres | terminated | Phase 2 | 6 | SCRI Development Innovations, LLCOTHER | 1 | Dec 5, 2023 | clinicaltrials |
| NCT06155994 | 68Ga-DOTA-MGS5 PET/CT in Patients With Advanced Neuroendocrine Tumours | completed | Phase 1 / Phase 2 | 12 | Medical University InnsbruckOTHER | 1 | Dec 5, 2023 | clinicaltrials |
| NCT03284775 | Intraoperative Ultrasound in Patients Undergoing Transsphenoidal Surgery for Pituitary Adenoma | completed | N/A | 5 | University College, LondonOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT00657332 | Clinical and Pathologic Studies in Neuroendocrine Tumors | withdrawn | — | 0 | Stanford UniversityOTHER | 0 | Nov 28, 2023 | clinicaltrials |
| NCT03724409 | Selective Intra-arterial Injection of PRRT in Neuroendocrine Tumor Patients With Liver Metastases | terminated | Early Phase 1 | 3 | Sandeep LaroiaOTHER | 1 | Nov 28, 2023 | clinicaltrials |
| NCT05709171 | Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms | unknown | Phase 2 | 200 | Rigshospitalet, DenmarkOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT06143605 | Clinical Relevance of the Salvage Treatment for Colorectal Neuroendocrine Tumors | completed | — | 527 | Yanhong DengOTHER | 0 | Nov 22, 2023 | clinicaltrials |
| NCT04602117 | ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer | withdrawn | Phase 1 | 0 | QuantumLeap Healthcare CollaborativeOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT02264665 | OPALINE : A Study Of Morbidity And Mortality At 2 Years(OPALINE) | completed | — | 144 | PfizerINDUSTRY | 1 | Nov 13, 2023 | clinicaltrials |
| NCT05523778 | A Multi-center Study to Evaluate the Efficacy and Safety of Pancreatic Duct Stents Placement Before the Enucleation of Insulinoma Located in the Head and Neck of the Pancreas Near the Main Pancreatic Duct | unknown | N/A | 78 | Peking Union Medical College HospitalOTHER | 1 | Nov 2, 2023 | clinicaltrials |
| NCT06080204 | Real-world Study on Adjuvant Octreotide Therapy in pNETs | completed | N/A | 411 | Changhai HospitalOTHER | 0 | Oct 18, 2023 | clinicaltrials |
Data updated 23 days agoSource updated May 7, 2024source: clinicaltrials